Omics technologies have made possible cost-efficient, high-throughput analysis of biologic molecules. Recent advances can be attributed to innovative breakthroughs in […]
Researchers have utilised lipid nanoparticles to deliver CRISPR technology and found that this technology could destroy cancer cells within an […]
As we continue to improve our understanding of cancer biology, one thing remains a game-changer for cancer care: the ability […]
Researchers have characterised the transcriptomic transformation of the human endometrium during the menstrual cycle at single-cell resolution. Human endometrium During […]
An international commission has stated that we need more research before gene editing can be used in babies and for […]
Cancer Research UK (CRUK), the University of Southampton and the London-based biotechnology company Touchlight Genetics have announced a new partnership […]
Genomics has the potential to improve efficacy of drugs and accelerate precision healthcare, but one area with the biggest potential […]
I recently interviewed marketing veteran Jeff Daniels on how organisations can overcome revenue hurdles during COVID-19. The following article summarises […]
Last week, we asked the genomics community how they were shifting their focus to help fight the novel coronavirus. We […]
Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.
